(2R*,5R*,6R*)-3-(TERT.-BUTYLDIMETHYLSILOXY)-5-(TERT.-BUTYLDIMETHYLSILYL)-6-FORMYL-5,6,7,8-TETRAHYDRO-2H-OXOCINE-2-CARBOXYLIC-ACID-METHYLESTER
Compound with spectra: 1 NMR
| SpectraBase Compound ID | Ht3e2y0oani |
|---|---|
| InChI | InChI=1S/C22H42O5Si2/c1-21(2,3)28(8,9)18-14-17(27-29(10,11)22(4,5)6)19(20(24)25-7)26-13-12-16(18)15-23/h14-16,18-19H,12-13H2,1-11H3/b17-14+/t16-,18-,19-/m0/s1 |
| InChIKey | AASRWDGMWYRIMF-VMROYELFSA-N |
| Mol Weight | 442.7 g/mol |
| Molecular Formula | C22H42O5Si2 |
| Exact Mass | 442.257078 g/mol |
| Enantiomer InChIKey | AASRWDGMWYRIMF-LNQWIVPISA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | C6D6 |
(1-R*,4-R*,5-R*)-4-(TERT.-BUTYLDIMETHYLSILYL)-2-(TERT.-BUTYLDIMETHYLSILOXY)-5-FORMYLCYCLOOCT-2-ENECARBOXYLIC_ACID_METHYLESTER
8-(TERT.-BUTYLDIMETHYLSILOXY)-6-TRIMETHYLSILYL-2-OXABICYCLO-[3.3.2]-DEC-7-EN-9-ONE
benzoic acid, 2-chloro-5-[3-mercapto-5-(2-thienyl)-4H-1,2,4-triazol-4-yl]-
3-ALPHA,7-ALPHA-DIHYDROXY-AMORPH-4-ENE-3-ACETATE
(2.beta.-(tert-Butyldimethylsilyloxy)-4.beta.-triethylsilyloxy-8-oxa-bicyclo[3.2.1]oct-6-en-3.beta.-yl)benzoate
(1S,2R,5R)-5-(6-aminopurin-9-yl)cyclopent-3-ene-1,2-diol
3,5-O-BIS-(TERT.-BUTYLDIMETHYLSILYL)-1-O-DIBENZYLPHOSPHATE-2,4,6-O-TRIBENZYL-D-MYO-INOSITOL
1-[6-(4-bromo-phenyl)-4-phenyl-2-phenylimino-cyclohex-3-enyl]-ethanone
3,4-BIS-O-TERT.-BUTYL-DIPHENYLSILYL-6-O-FORMYL-D-GLUCAL
3'-O-TERT.-BUTYLDIPHENYLSILYL-2,3-O-ISOPROPYLIDENE-D-APIO-D-FURANOSE;ISOMER-ALPHA
| Title | Journal or Book | Year |
|---|---|---|
| Stereoselective Construction of Eight-Membered Oxygen Heterocycles by Brook Rearrangement-Mediated [3 + 4] Annulation | Organic Letters | 2004 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.